Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1

Interventions

pembrolizumab 195 Nivolumab 146 Carboplatin 134 Specimen Handling 130 Magnetic Resonance Spectroscopy 115 Cyclophosphamide 109 Paclitaxel 106 Cisplatin 98 Biopsy 97 Radiotherapy 90 durvalumab 81 Dexamethasone 79 atezolizumab 73 Ipilimumab 62 Gemcitabine 62 Rituximab 59 Doxorubicin 59 Lenalidomide 55 Docetaxel 55 olaparib 52 Bevacizumab 51 Capecitabine 50 Fluorouracil 49 Etoposide 49 Radiation 47 Oxaliplatin 47 Radiosurgery 42 Prednisone 42 venetoclax 41 Taxes 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × lanreotide × Clear all

NCT03946527 2026-03-02

LAMPARA

Columbia University

Phase 2 Active not recruiting

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡